Lifestyle interventions in nonalcoholic fatty liver disease (original) (raw)

• Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).
  Article PubMed Google Scholar
• Le, M. H. et al. 2019 Global NAFLD prevalence: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 20, 2809–2817 (2022).
  Article PubMed Google Scholar
• Younossi, Z. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review of the prevalence, incidence and mortality. Hepatology 10, 1097 (2023).
  Google Scholar
• World Health Organization. Diabetes. WHO https://www.who.int/health-topics/diabetes#tab=tab_1 (2023).
• World Health Organization. Obesity. WHO https://www.who.int/health-topics/obesity#tab=tab_1 (2023).
• Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739–752 (2020).
  Article PubMed Google Scholar
• Zou, B. et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. J. Intern. Med. 288, 139–151 (2020).
  Article CAS PubMed Google Scholar
• Golabi, P. et al. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol. Commun. 19, 1136–1148 (2020).
  Article Google Scholar
• Le, M. H. et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin. Mol. Hepatol. 28, 841–850 (2022).
  Article PubMed PubMed Central Google Scholar
• Estes, C. et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123–133 (2018).
  Article CAS PubMed Google Scholar
• Loomba, R. et al. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 13, 2537–2564 (2021).
  Article Google Scholar
• Sanyal, A. J. et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559–1569 (2021).
  Article CAS PubMed PubMed Central Google Scholar
• Zou, B. et al. Fatty liver index and development of cardiovascular disease: findings from the UK biobank. Dig. Dis. Sci. 66, 2092–2100 (2021).
  Article PubMed Google Scholar
• Younossi, Z. M. et al. Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the Global Non-alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry. Clin. Gastroenterol. Hepatol. 9, S1542–S3565 (2021).
  Google Scholar
• Younossi, Z. M. et al. Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes. Hepatol. Commun. 4, 1637–1650 (2020).
  Article CAS PubMed PubMed Central Google Scholar
• Younossi, Z. M. et al. Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States. Hepatology 69, 564–572 (2019).
  Article PubMed Google Scholar
• Younossi, Z. M. et al. Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the U.S. Diabetes Care 43, 283–289 (2020).
  Article PubMed Google Scholar
• Tampi, R. P. et al. Modelling the economic and clinical burden of nonalcoholic steatohepatitis in East Asia: data from Hong Kong. Hepatol. Res. 50, 1024–1031 (2020).
  Article PubMed Google Scholar
• Nguyen, A. L. et al. Rising inpatient encounters and economic burden for patients with nonalcoholic fatty liver disease in the USA. Dig. Dis. Sci. 64, 698–707 (2019).
  Article CAS PubMed Google Scholar
• Younossi, Z. M. et al. The growing economic and clinical burden of nonalcoholic steatohepatitis (NASH) in the United States (U.S.). J. Clin. Exper. Hepatol. 13, 454–467 (2023).
  Article CAS Google Scholar
• Alqahtani, S. A. et al. Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol. Commun. 5, 1833–1847 (2021).
  Article PubMed PubMed Central Google Scholar
• Younossi, Z. M. et al. Global nonalcoholic steatohepatitis council. A global survey of physicians knowledge about nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 20, e1456–e1468 (2022).
  Article CAS PubMed Google Scholar
• Cusi, K. et al. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr. Pract. 28, 528–562 (2022).
  Article PubMed Google Scholar
• Long, M. T. et al. AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review. Gastroenterology 163, 764–774 (2022).
  Article PubMed Google Scholar
• Anstee, Q. M. et al. Impact of non-invasive biomarkers on hepatology practice: past, present and future. J. Hepatol. 76, 1362–1378 (2022).
  Article CAS PubMed Google Scholar
• Hagström, H. et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J. Hepatol. 67, 1265–1273 (2017).
  Article PubMed Google Scholar
• Dulai, P. S. et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 5, 1557–1565 (2017).
  Article Google Scholar
• Koutoukidis, D. A. et al. Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern. Med. 179, 1262–1271 (2019).
  Article PubMed PubMed Central Google Scholar
• Golabi, P. et al. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review. World J. Gastroenterol. 22, 6318–6327 (2016).
  Article PubMed PubMed Central Google Scholar
• Younossi, Z. M. et al. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review. Gastroenterology 160, 912–918 (2021).
  Article PubMed Google Scholar
• Vilar-Gomez, E. et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367–378 (2015).
  Article PubMed Google Scholar
• Marin-Alejandre, B. A. et al. Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: a randomized trial. Liver Int. 41, 1532–1544 (2021).
  Article CAS PubMed Google Scholar
• Properzi, C. et al. Ad libitum mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology 68, 1741–1754 (2018).
  Article CAS PubMed Google Scholar
• Katsagoni, C. N. et al. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Br. J. Nutr. 120, 164–175 (2018).
  Article CAS PubMed Google Scholar
• Misciagna, G. et al. Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial. J. Nutr. Health Aging 21, 404–412 (2017).
  Article CAS PubMed Google Scholar
• Abenavoli, L. et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients 9, 8 (2017).
  Article Google Scholar
• Kawaguchi, T. et al. Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials. Semin. Liver Dis. 41, 225–234 (2021).
  Article PubMed Google Scholar
• Haigh, L. et al. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Clin. Nutr. 41, 1913–1931 (2022).
  Article CAS PubMed Google Scholar
• Thomsen, M. N. et al. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 65, 506–517 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Gepner, Y. et al. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. Circulation 137, 1143–1157 (2018).
  Article PubMed Google Scholar
• Skytte, M. J. et al. A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial. Diabetologia 62, 2066–2078 (2019).
  Article CAS PubMed Google Scholar
• Jang, E. C., Jun, D. W., Lee, S. M., Cho, Y. K. & Ahn, S. B. Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: a randomized controlled study. Hepatol. Res. 48, E22–E29 (2018).
  Article CAS PubMed Google Scholar
• Otten, J. et al. Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention. Int. J. Obes. 40, 747–753 (2016).
  Article CAS Google Scholar
• Ahn, J., Jun, D. W., Lee, H. Y. & Moon, J. H. Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: review and meta-analyses. Clin. Nutr. 38, 2023–2030 (2019).
  Article CAS PubMed Google Scholar
• Xu, C. et al. High‐protein diet more effectively reduces hepatic fat than low‐protein diet despite lower autophagy and FGF21 levels. Liver Int. 40, 2982–2997 (2020).
  Article CAS PubMed Google Scholar
• Markova, M. et al. Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes. Gastroenterology 152, 571–585 (2017).
  Article CAS PubMed Google Scholar
• Holmer, M. et al. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet — a randomised controlled trial. JHEP Rep. 3, 100256 (2021).
  Article PubMed PubMed Central Google Scholar
• Yaskolka, M. A. et al. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut 70, 2085–2095 (2021).
  Article Google Scholar
• Zelber-Sagi, S. et al. One size does not fit all; practical, personal tailoring of the diet to NAFLD patients. Liver Int. 42, 1731–1750 (2022).
  Article PubMed Google Scholar
• American College of Cardiology. Guidelines made simple; 2019 guideline on the primary prevention of cardiovascular disease. American College of Cardiology http://www.onlinejacc.org/sites/default/files/additional_assets/guidelines/Prevention-Guidelines-Made-Simple.pdf (2019).
• US Department of Health and Human Service. Dietary guidelines for Americans. US Department of Health and Human Service https://health.gov/dietaryguidelines/ (2022).
• Turati, F. et al. Mediterranean diet and hepatocellular carcinoma. J. Hepatol. 60, 606–611 (2014).
  Article PubMed Google Scholar
• Ma, Y. et al. Dietary patterns and risk of hepatocellular carcinoma among U.S. men and women. Hepatology 70, 577–586 (2019).
  Article CAS PubMed Google Scholar
• Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology https://doi.org/10.1097/HEP.0000000000000323 (2023).
  Article PubMed Google Scholar
• Francque, S. M. et al. Non-alcoholic fatty liver disease: a patient guideline. JHEP Rep. 3, 100322 (2021).
  Article PubMed PubMed Central Google Scholar
• Plauth, M. et al. ESPEN guideline on clinical nutrition in liver disease. Clin. Nutr. 38, 485–521 (2019).
  Article PubMed PubMed Central Google Scholar
• Srour, B. et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé). BMJ 29, 1451 (2019).
  Article Google Scholar
• Schnabel, L. et al. Association between ultraprocessed food consumption and risk of mortality among middle-aged adults in France. JAMA Intern. Med. 179, 490–498 (2019).
  Article PubMed PubMed Central Google Scholar
• Zhang, S. et al. Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic low-grade systemic inflammation and health cohort study. Int. J. Epidemiol. 51, 237–249 (2022).
  Article PubMed Google Scholar
• Ivancovsky-Wajcman, D. et al. High meat consumption is prospectively associated with the risk of non-alcoholic fatty liver disease and presumed significant fibrosis. Nutrients 14, 3533 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Hassani Zadeh, S. et al. Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 36, 1470–1478 (2021).
  Article PubMed Google Scholar
• Paik, J. M. et al. Dietary risks for liver mortality in NAFLD: global burden of disease data. Hepatol. Commun. 6, 90–100 (2022).
  Article CAS PubMed Google Scholar
• Luukkonen, P. K. et al. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 41, 1732–1739 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Willett, W. et al. Food in the anthropocene: the EAT-lancet commission on healthy diets from sustainable food systems. Lancet 393, 447–492 (2019).
  Article PubMed Google Scholar
• Saeed, N. et al. Evaluation of dietary approaches for the treatment of non-alcoholic fatty liver disease: a systematic review. Nutrients 16, 3064 (2019).
  Article Google Scholar
• Yki-Jarvinen, H. et al. Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 18, 770–786 (2021).
  Article CAS PubMed Google Scholar
• Simons, N. et al. Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial. Am. J. Clin. Nutr. 113, 391–400 (2021).
  Article PubMed Google Scholar
• Geidl-Flueck, B. et al. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: a randomized controlled trial. J. Hepatol. 75, 46–54 (2021).
  Article CAS PubMed Google Scholar
• Geurtsen, M. L. et al. Associations between intake of sugar-containing beverages in infancy with liver fat accumulation at school age. Hepatology 73, 560–570 (2021).
  Article CAS PubMed Google Scholar
• He, K. et al. Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br. J. Nutr. 124, 1–13 (2020).
  Article CAS PubMed PubMed Central Google Scholar
• Mosca, A. et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J. Hepatol. 66, 1031–1036 (2017).
  Article CAS PubMed Google Scholar
• Zhang, S. et al. Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. Am. J. Clin. Nutr. 113, 1265–1274 (2021).
  Article PubMed Google Scholar
• Schwarz, J. M. et al. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology 153, 743–752 (2017).
  Article CAS PubMed Google Scholar
• Schwimmer, J. B. et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial. J. Am. Med. Assoc. 321, 256–265 (2019).
  Article Google Scholar
• Hayat, U. et al. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies. Ann. Hepatol. 20, 100254 (2021).
  Article CAS PubMed Google Scholar
• Chen, Y. P. et al. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. Clin. Nutr. 38, 2552–2557 (2019).
  Article CAS PubMed Google Scholar
• Niezen, S. et al. Coffee consumption is associated with lower liver stiffness: a nationally representative study. Clin. Gastroenterol. Hepatol. 20, 2032–2040 (2022).
  Article CAS PubMed Google Scholar
• Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675–1685 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ivancovsky-Wajcman, D. et al. Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease. Dig. Liver Dis. 51, 1698–1705 (2019).
  Article CAS PubMed Google Scholar
• Salomone, F. et al. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. JHEP Rep. 28, 100069 (2020).
  Article Google Scholar
• Zelber-Sagi, S. et al. Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 49, 523–529 (2017).
  Article CAS PubMed Google Scholar
• Ivancovsky-Wajcman, D. et al. Serum soluble receptor for AGE (sRAGE) levels are associated with unhealthy lifestyle and nonalcoholic fatty liver disease. Clin. Transl. Gastroenterol. 22, 1–10 (2019).
  Google Scholar
• Yilmaz, Y. et al. Decreased plasma levels of soluble receptor for advanced glycation end products (sRAGE) in patients with nonalcoholic fatty liver disease. Clin. Biochem. 42, 802–807 (2009).
  Article CAS PubMed Google Scholar
• Uribarri, J. et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 110, 911–916.e12 (2010).
  Article PubMed PubMed Central Google Scholar
• Van Dongen, C. et al. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatol. Commun. 6, 3140–3153 (2022).
  Article PubMed PubMed Central Google Scholar
• Golabi, P. et al. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Rep. 2, 100171 (2020).
  Article PubMed PubMed Central Google Scholar
• Ganapathy, A. & Nieves, J. W. Nutrition and sarcopenia — what do we know? Nutrients 11, 1755 (2020).
  Article Google Scholar
• Fernández-Mincone, T. et al. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Rev. Gastroenterol. Hepatol. 14, 1141–1157 (2020).
  Article PubMed Google Scholar
• Harring, M. et al. Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis. Clin. Gastroenterol. Hepatol. 25, S1542–S3565 (2023).
  Google Scholar
• Zelber-Sagi, S., Ivancovsky-Wajcman, D., Rabinowich, L., Bentov, I. & Deutsch, L. Nutritional evaluation and treatment of the Cirrhotic patient. Clin. Liver Dis. 25, 373–392 (2021).
  Article PubMed Google Scholar
• Lai, J. C. et al. Malnutrition, frailty, and sarcopenia in patients with Cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 74, 1611–1644 (2021).
  Article PubMed Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease. J. Hepatol. 70, 172–193 (2019).
  Article Google Scholar
• Akhavan Rezayat, A. et al. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 6, 2050312117745223 (2018).
  Article PubMed PubMed Central Google Scholar
• Peng, X. et al. Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials. BMC Endocr. Disord. 22, 95 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Marti-Aguado, D. et al. Cigarette smoking and liver diseases. J. Hepatol. 77, 191–205 (2022).
  Article CAS PubMed Google Scholar
• Hagstrom, H. et al. Cardiovascular risk factors in non-alcoholic fatty liver disease. Liver Int. 39, 197–204 (2019).
  Article PubMed Google Scholar
• National Institute of Alcohol Abuse. Drink alcohol only in moderation. National Institute of Alcohol Abuse https://health.gov/myhealthfinder/health-conditions/heart-health/drink-alcohol-only-moderation#:~:Text=A%20moderate%20amount%20of%20alcohol%20means%3A,in%20a%20day%20for%20men (2022).
• Aberg, F. & Farkkila, M. Drinking and obesity: alcoholic liver disease/nonalcoholic fatty liver disease interactions. Semin. Liver Dis. 40, 154–162 (2020).
  Article PubMed Google Scholar
• Long, M. T. et al. Alcohol use is associated with hepatic steatosis among persons with presumed nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 18, 1831–1841 (2020).
  Article PubMed Google Scholar
• Blomdahl, J. et al. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus. Metabolism 115, 154439 (2021).
  Article CAS PubMed Google Scholar
• Davis, J. N. et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am. J. Clin. Nutr. 92, 1522–1527 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Santoro, N. et al. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One 7, e37827 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vilar-Gomez, E. et al. Impact of the association between PNPLA3 genetic variation and dietary intake on the risk of significant fibrosis in patients with NAFLD. Am. J. Gastroenterol. 116, 994–1006 (2021).
  Article CAS PubMed PubMed Central Google Scholar
• Shen, J. et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 30, 139–146 (2015).
  Article CAS PubMed Google Scholar
• Sevastianova, K. et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am. J. Clin. Nutr. 94, 104–111 (2011).
  Article CAS PubMed Google Scholar
• Nishioji, K. et al. The impact of PNPLA3 rs738409 genetic polymorphism and weight gain ≥10 kg after age 20 on non-alcoholic fatty liver disease in non-obese japanese individuals. PLoS One 10, e0140427 (2015).
  Article PubMed PubMed Central Google Scholar
• Nguyen, V. H. et al. Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD. J. Intern. Med. 289, 840–850 (2021).
  Article CAS PubMed Google Scholar
• Kamada, Y. et al. Japan Study Group of NAFLD (JSG‐NAFLD). Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. J. Gastroenterol. 56, 1045–1061 (2021).
  Article CAS PubMed Google Scholar
• George, E. S. et al. A Mediterranean diet model in Australia: strategies for translating the traditional Mediterranean diet into a multicultural setting. Nutrients 10, 465 (2018).
  Article PubMed PubMed Central Google Scholar
• Trovato, F. M. et al. Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity. Hepatobiliary Surg. Nutr. 8, 167–169 (2019).
  Article PubMed PubMed Central Google Scholar
• Centers for Disease Control and Prevention. How much physical activity do adults need? CDC https://www.cdc.gov/physicalactivity/basics/adults/index.htm (2022).
• Heredia, N. I. et al. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018. Prev. Med. 154, 106903 (2022).
  Article PubMed Google Scholar
• Katsagoni, C. N. et al. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis. Metabolism 68, 119–132 (2017).
  Article CAS PubMed Google Scholar
• US Department of Health and Human Services. Physical activity guidelines for Americans. US Department of Health and Human Services https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf (2023).
• Kim, D. et al. Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease. Hepatology 72, 1556–1568 (2020).
  Article CAS PubMed Google Scholar
• Kim, D. et al. Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan. Clin. Gastroenterol. Hepatol. 20, e1438–e1455 (2022).
  Article CAS PubMed Google Scholar
• Henry, A. et al. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Aliment. Pharmacol. Ther. 57, 709–722 (2023).
  Article CAS PubMed Google Scholar
• Hashida, R. et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J. Hepatol. 66, 142–152 (2017).
  Article PubMed Google Scholar
• Zelber-Sagi, S. et al. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J. Gastroenterol. 20, 4382–4392 (2014).
  Article PubMed PubMed Central Google Scholar
• Keating, S. E., Hackett, D. A., George, J. & Johnson, N. A. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Hepatol. 57, 157–166 (2012).
  Article CAS PubMed Google Scholar
• Orci, L. A. et al. Exercise-based Interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin. Gastroenterol. Hepatol. 14, 1398–1411 (2016).
  Article PubMed Google Scholar
• Qiu, S. et al. Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis. Ther. Adv. Gastroenterol. 10, 701–713 (2017).
  Article Google Scholar
• González-Ruiz, K. et al. The effects of exercise on abdominal fat and liver enzymes in pediatric obesity: a systematic review and meta-analysis. Child. Obes. 13, 272–282 (2017).
  Article PubMed Google Scholar
• Medrano, M. et al. Evidence-based exercise recommendations to reduce hepatic fat content in youth — a systematic review and meta-analysis. Prog. Cardiovasc. Dis. 61, 222–231 (2018).
  Article PubMed Google Scholar
• Smart, N. A., King, N., McFarlane, J. R., Graham, P. L. & Dieberg, G. Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis. Br. J. Sports Med. 52, 834–843 (2018).
  Article CAS PubMed Google Scholar
• Utz-Melere, M. et al. Non-alcoholic fatty liver disease in children and adolescents: lifestyle change — a systematic review and meta-analysis. Ann. Hepatol. 17, 345–354 (2018).
  Article CAS PubMed Google Scholar
• Sargeant, J. A. et al. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. Obes. Rev. 19, 1446–1459 (2018).
  Article CAS PubMed Google Scholar
• Zou, T. T. et al. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. Eur. J. Gastroenterol. Hepatol. 30, 747–755 (2018).
  Article PubMed Google Scholar
• Wang, S. T. et al. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 20, 66 (2020).
  Article CAS PubMed PubMed Central Google Scholar
• Baker, C. J. et al. Effect of exercise on hepatic steatosis: are benefits seen without dietary intervention? A systematic review and meta-analysis. J. Diabetes 13, 63–77 (2021).
  Article CAS PubMed Google Scholar
• Xiong, Y., Peng, Q., Cao, C., Xu, Z. & Zhang, B. Effect of different exercise methods on non-alcoholic fatty liver disease: a meta-analysis and meta-regression. Int. J. Env. Res. Public Health 18, 3242 (2021).
  Article Google Scholar
• Babu, A. F. et al. Positive effects of exercise intervention without weight loss and dietary changes in NAFLD-related clinical parameters: a systematic review and meta-analysis. Nutrients 13, 3135 (2021).
  Article CAS PubMed PubMed Central Google Scholar
• Sabag, A. et al. The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 17, 862–881 (2022).
  Article Google Scholar
• Fernández, T., Viñuela, M., Vidal, C. & Barrera, F. Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. PLoS One 17, e0263931 (2022).
  Article PubMed PubMed Central Google Scholar
• Houttu, V. et al. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis. Front. Endocrinol. 13, 1032164 (2022).
  Article Google Scholar
• Ghaffari, M., Sadeghiyan, S., Faramarzi, M., Moghaddam, M. & Baghurst, T. The effect of aerobic exercise on metabolic parameters of patients with non-alcoholic fatty liver disease: systematic review and meta-analysis. J. Sports Med. Phys. Fit. 63, 178–187 (2023).
  Google Scholar
• Reddy, Y. K. et al. Natural history of non-alcoholic fatty liver disease: a study with paired liver biopsies. J. Clin. Exp. Hepatol. 10, 245–254 (2020).
  Article PubMed Google Scholar
• Leslie, T. et al. Survey of health status, nutrition and geography of food selection of chronic liver disease patients. Ann. Hepatol. 13, 533–540 (2014).
  Article PubMed Google Scholar
• Frankenfeld, C. L., Leslie, T. F. & Makara, M. A. Diabetes, obesity, and recommended fruit and vegetable consumption in relation to food environment sub-types: a cross-sectional analysis of Behavioral Risk Factor Surveillance System, United States Census, and food establishment data. BMC Public Health 15, 491 (2015).
  Article PubMed PubMed Central Google Scholar
• Haynes-Maslow, L. & Leone, L. A. Examining the relationship between the food environment and adult diabetes prevalence by county economic and racial composition: an ecological study. BMC Public Health 17, 648 (2017).
  Article PubMed PubMed Central Google Scholar
• Giammarino, A. M. Community socioeconomic deprivation predicts nonalcoholic steatohepatitis. Hepatol. Commun. 6, 550–560 (2022).
  Article PubMed Google Scholar
• Talens, M. et al. What do we know about inequalities in NAFLD distribution and outcomes? A scoping review. J. Clin. Med. 10, 5019 (2021).
  Article PubMed PubMed Central Google Scholar
• Kaiser, M. L., Dionne, J. & Carr, J. K. Predictors of diet-related health outcomes in food-secure and food-insecure communities. Soc. Work Public Health 34, 214–229 (2019).
  Article PubMed Google Scholar
• Keenan, G. S., Christiansen, P. & Hardman, C. A. Household food insecurity, diet quality, and obesity: an explanatory model. Obesity 29, 143–149 (2021).
  Article PubMed Google Scholar
• Vilar-Gomez, E. et al. High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology 75, 1491–1506 (2022).
  Article PubMed Google Scholar
• US Department of Agriculture. Definition of food security. USDA https://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in-the-u-s/definitions-of-food-security/#:~:Text=Food%20insecurity%E2%80%94the%20condition%20assessed,may%20result%20from%20food%20insecurity (2022).
• Eskandari, F., Lake, A. A., Rose, K., Butler, M. & O’Malley, C. A mixed-method systematic review and meta-analysis of the influences of food environments and food insecurity on obesity in high-income countries. Food Sci. Nutr. 10, 3689–3723 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Golovaty, I. et al. Food insecurity may be an independent risk factor associated with nonalcoholic fatty liver disease among low-income adults in the United States. J. Nutr. 150, 91–98 (2020).
  Article PubMed Google Scholar
• Kardashian, A., Dodge, J. L. & Terrault, N. A. Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population-based study. Aliment. Pharmacol. Ther. 56, 1383–1393 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Leung, C. W. & Tester, J. M. The association between food insecurity and diet quality varies by race/ethnicity: an analysis of national health and nutrition examination survey 2011-2014 results. J. Acad. Nutr. Diet. 119, 1676–1686 (2019).
  Article PubMed Google Scholar
• Castellanos-Fernández, M. I. et al. A multi-center study exploring the association of metabolic syndrome and non-alcoholic fatty liver disease in Cuban patients. Austin J. Obes. Metab. Synd. 5, 1023 (2021).
  Google Scholar
• Asadullah, M. et al. Rural-urban differentials in prevalence, spectrum and determinants of non-alcoholic fatty liver disease in North Indian population. PLoS One 17, e0263768 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Patel, K. et al. A retrospective observational cohort study to assess the prevalence and survival of patients with nonalcoholic steatohepatitis in Ontario, Canada. Hepatology 72, 63A–64A (2020).
  Google Scholar
• Hales, C. M. et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016. J. Am. Med. Assoc. 319, 2419–2429 (2018).
  Article Google Scholar
• Zhu, J. Z. et al. Prevalence of nonalcoholic fatty liver disease and economy. Dig. Dis. Sci. 60, 3194–3202 (2015).
  Article CAS PubMed Google Scholar
• Oldroyd, L., Eskandari, F., Pratt, C. & Lake, A. A. The nutritional quality of food parcels provided by food banks and the effectiveness of food banks at reducing food insecurity in developed countries: a mixed-method systematic review. J. Hum. Nutr. Diet. 35, 1202–1229 (2022).
  Article PubMed PubMed Central Google Scholar
• den Braver, N. R. et al. Built environmental characteristics and diabetes: a systematic review and meta-analysis. BMC Med. 16, 12 (2018).
  Article Google Scholar
• Kärmeniemi, M. et al. The built environment as a determinant of physical activity: a systematic review of longitudinal studies and natural experiments. Ann. Behav. Med. 52, 239–251 (2018).
  Article PubMed Google Scholar
• Chandrabose, M. et al. Built environment and cardio-metabolic health: systematic review and meta-analysis of longitudinal studies. Obes. Rev. 20, 41–54 (2019).
  Article CAS PubMed Google Scholar
• Guo, B. et al. China multi-ethnic cohort (CMEC) collaborative group. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. J. Hepatol. 76, 518–525 (2022).
  Article CAS PubMed Google Scholar
• Liu, F. et al. Associations between long-term exposure to ambient air pollution and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Env. Pollut. 252, 1235–1245 (2019).
  Article CAS Google Scholar
• VoPham, T. et al. PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample. Environ. Res. 213, 113611 (2022).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, S. et al. Long-term exposure to fine particulate matter and non-alcoholic fatty liver disease: a prospective cohort study. Gut 71, 443–445 (2022).
  Article PubMed Google Scholar
• Adkins, A., Makarewicz, C., Scanze, M., Ingram, M. & Luhr, G. Contextualizing walkability: do relationships between built environments and walking vary by socioeconomic context? J. Am. Plan. Assoc. 83, 296–314 (2017).
  Article Google Scholar
• Hoenink, J. C. et al. The moderating role of social neighbourhood factors in the association between features of the physical neighbourhood environment and weight status. Obes. Facts 12, 14–24 (2019).
  Article PubMed PubMed Central Google Scholar
• Cutts, B. B., Darby, K. J., Boone, C. G. & Brewis, A. City structure, obesity, and environmental justice: an integrated analysis of physical and social barriers to walkable streets and park access.Soc. Sci. Med. 69, 1314–1322 (2009).
  Article PubMed Google Scholar
• Guilcher, S. J. T. et al. The association between social cohesion in the neighborhood and body mass index (BMI): an examination of gendered differences among urban dwelling Canadians. Prev. Med. 99, 293–298 (2017).
  Article PubMed Google Scholar
• Lovasi, G. S., Neckerman, K. M., Quinn, J. W., Weiss, C. C. & Rundle, A. Effect of individual or neighborhood disadvantage on the association between neighborhood walkability and body mass index. Am. J. Public Health 99, 279–284 (2009).
  Article PubMed PubMed Central Google Scholar
• Sallis, J. F. et al. Neighborhood built environment and socioeconomic status in relation to physical activity, sedentary behavior, and weight status of adolescents. Prev. Med. 110, 47–54 (2018).
  Article PubMed PubMed Central Google Scholar
• Yu, E. L. & Schwimmer, J. B. Epidemiology of pediatric nonalcoholic fatty liver disease. Clin. Liver Dis. 17, 196–199 (2021).
  Article Google Scholar
• Elizabeth, L. Y. et al. Prevalence of nonalcoholic fatty liver disease in children with obesity. J. Paediatr. 207, 64–70 (2019).
  Article Google Scholar
• Anderson, E. L. et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One 10, e0140908 (2015).
  Article PubMed PubMed Central Google Scholar
• Li, J., Le, M. H., Barakat, M. T., Cheung, R. C. & Nguyen, M. H. The changing epidemiology of liver disease among US children and adolescents from 1999 to 2016. Am. J. Gastroenterol. 11, 2068–2078 (2021).
  Article Google Scholar
• Arshad, T. et al. Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007-2016. Hepatol. Commun. 5, 1676–1688 (2021).
  Article CAS PubMed PubMed Central Google Scholar
• Selvakumar, P. K. C., Kabbany, M. N., Nobili, V. & Alkhouri, N. Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications. Pediatr. Clin. North Am. 64, 659–675 (2017).
  Article PubMed Google Scholar
• Zimmermann, E. et al. Body mass index in school‐aged children and the risk of routinely diagnosed non‐alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register. BMJ Open 5, e006998 (2015).
  Article PubMed PubMed Central Google Scholar
• Perito, E. R. et al. Hepatic steatosis after pediatric liver transplant. Liver Transpl. 23, 957–967 (2017).
  Article PubMed PubMed Central Google Scholar
• Costa, C. S. et al. Ultra-processed food consumption and its effects on anthropometric and glucose profile: a longitudinal study during childhood. Nutr. Metab. Cardiovasc. Dis. 29, 177–184 (2019).
  Article CAS PubMed Google Scholar
• Fismen, A. S. et al. Socioeconomic differences in food habits among 6- to 9-year-old children from 23 countries — WHO European Childhood Obesity Surveillance Initiative (COSI 2015/2017). Obes. Rev. 22, e13211 (2021).
  Article PubMed Google Scholar
• Muth, N. D., Dietz, W. H., Magge, S. N. & Johnson, R. K.; American Academy of Pediatrics; Section on Obesity; Committee on Nutrition; American Heart Association. Public policies to reduce sugary drink consumption in children and adolescents. Pediatrics 143, e20190282 (2019).
  Article PubMed Google Scholar
• McLaughlin, K. A., Weissman, D. & Bitrán, D. Childhood adversity and neural development: a systematic review. Ann. Rev. Dev. Psychol. 1, 277–312 (2019).
  Article Google Scholar
• Hughes, K. et al. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health 2, e356–e366 (2017).
  Article PubMed Google Scholar
• Deng, K. & Lacey, R. E. Adverse childhood experiences, child poverty, and adiposity trajectories from childhood to adolescence: evidence from the Millennium Cohort Study. Int. J. Obes. 46, 1792–1800 (2022).
  Article Google Scholar
• Wiehn, J., Hornberg, C. & Fischer, F. How adverse childhood experiences relate to single and multiple health risk behaviours in German public university students: a cross-sectional analysis. BMC Public Health 18, 1005 (2018).
  Article PubMed PubMed Central Google Scholar
• Schroeder, K., Schuler, B. R., Kobulsky, J. M. & Sarwer, D. B. The association between adverse childhood experiences and childhood obesity: a systematic review. Obes. Rev. 22, e13204 (2021).
  Article PubMed PubMed Central Google Scholar
• Singhal, J., Herd, C., Adab, P. & Pallan, M. Effectiveness of school-based interventions to prevent obesity among children aged 4 to 12 years old in middle-income countries: a systematic review and meta-analysis. Obes. Rev. 22, e13105 (2021).
  Article PubMed Google Scholar
• MacArthur, G. et al. Individual-, family-, and school-level interventions targeting multiple risk behaviours in young people. Cochrane Database Syst. Rev. 10, CD009927 (2018).
  PubMed Google Scholar
• Martin, A. et al. Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight. Cochrane Database Syst. Rev. 1, CD009728 (2018).
  PubMed Google Scholar
• Dudley, D. A., Cotton, W. G. & Peralta, L. R. Teaching approaches and strategies that promote healthy eating in primary school children: a systematic review and meta-analysis. Int. J. Behav. Nutr. Phys. Act. 25, 28 (2015).
  Article Google Scholar
• Karlsen, T. H. et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399, 61–116 (2022).
  Article PubMed Google Scholar
• Younes, R. & Bugianesi, E. NASH in lean individuals. Semin. Liver Dis. 39, 86–95 (2019).
  Article CAS PubMed Google Scholar
• Sookoian, S. & Pirola, C. J. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment. Pharmacol. Ther. 46, 85–95 (2017).
  Article CAS PubMed Google Scholar
• Chen, F. et al. Lean NAFLD: a distinct entity shaped by differential metabolic adaptation. Hepatology 71, 1213–1227 (2020).
  Article CAS PubMed Google Scholar
• Wong, V. W. et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J. Hepatol. 69, 1349–1356 (2018).
  Article PubMed Google Scholar
• Sinn, D. H. et al. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 33, e529–e534 (2021).
  Article CAS PubMed Google Scholar
• Kempf, K. et al. Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care 40, 863–871 (2017).
  Article CAS PubMed Google Scholar
• Mazzotti, A. et al. An internet-based approach for lifestyle changes in patients with NAFLD: two-year effects on weight loss and surrogate markers. J. Hepatol. 69, 1155–1163 (2018).
  Article PubMed Google Scholar
• Petroni, M. L. et al. Lifestyle intervention in NAFLD: long-term diabetes incidence in subjects treated by web- and group-based programs. Nutrients 15, 792 (2023).
  Article PubMed PubMed Central Google Scholar
• Pfirrmann, D., Huber, Y., Schattenberg, J. M. & Simon, P. Web-based exercise as an effective complementary treatment for patients with nonalcoholic fatty liver disease: intervention study. J. Med. Internet Res. 21, e11250 (2019).
  Article PubMed PubMed Central Google Scholar
• Huber, Y. et al. Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. Aliment. Pharmacol. Ther. 50, 930–939 (2019).
  Article CAS PubMed Google Scholar